# OnCo record 4sc (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/4sc/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "4sc" ;
  schema:name "4SC"@en ;
  schema:alternateName "4SC AG"@en, "4Sc AG"@en ;
  schema:description "4SC is a listed German biotechnology company founded in 1997 in Planegg-Martinsried, near Munich. It applied to the EMA for its HDAC inhibitor resminostat (Kinselby) in advanced mycosis fungoides and Sézary syndrome and received a negative opinion in May 2025."@en ;
  schema:url <https://onco.cc/companies/4sc/>, <https://www.4sc.com/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.4sc.com/>, <https://www.wikidata.org/wiki/Q238181>, <https://www.ema.europa.eu/en/medicines/human/EPAR/kinselby> ;
  onco:tag "ctgov-sponsor", "wave5-sponsor" ;
  schema:addressCountry "DE" ;
  onco:cancers <https://onco.cc/cancers/cutaneous-t-cell-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/epigenetic-drugs/> ;
  onco:targets <https://onco.cc/targets/hdac/> ;
  onco:drugs <https://onco.cc/drugs/resminostat/> .